Celgene provides hint at what tax reform could mean for M&A, if it ever happens
admin 11th December 2017 Uncategorised 0As pharma waits to see if Congress gets to the finish line with a promised tax cut for business, Celgene provided some insight on Sunday into what it could mean as far as M&A for the industry. The New Jersey drugmaker has $9 billion overseas that might be deployed, upping its purchasing power by 50%.
More: Celgene provides hint at what tax reform could mean for M&A, if it ever happens
Source: fierce